Esofagitis candidiásica en un paciente no inmunodeprimido
Nuevo, JA; Hijano, A; Eimil, M; Valdivia, A; Candel, FJ; Núñez, MJ; Roca, V.
Rev. esp. enferm. dig
; 94(8): 503-504, ago. 2002.
Artículo en Es | IBECS (España) | ID: ibc-19138
Documentos relacionados
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates.
Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
Synergy In Vitro of Nikkomycin Z with Azole Against the Invasive Form of Candida albicans.
First description of Candida haemulonii infecting a snake Boa constrictor: Molecular, pathological and antifungal sensitivity characteristics.
A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance.
Effect of intravaginal gentian violet for acute vaginal candidiasis treated with a single dose oral fluconazole: a randomised controlled trial.
<i>Candida</i> meningitis/ventriculitis over a decade. Increased morbidity and length of stay a concern.
Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy.
Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections.
Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.